{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:37:19Z","timestamp":1780472239629,"version":"3.54.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Globally, there is wide variation in streptococcal titer upper limits of normal (ULN) for antistreptolysin O (ASO) and anti-deoxyribonuclease B (ADB) used as an evidence of recent group A streptococcal infection to diagnose acute rheumatic fever (ARF).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We audited ASO and ADB titers among individuals with ARF in New Zealand (NZ) and in Australia\u2019s Northern Territory. We summarized streptococcal titers by different ARF clinical manifestations, assessed application of locally recommended serology guidelines where NZ uses high ULN cut-offs and calculated the proportion of cases fulfilling alternative serologic diagnostic criteria.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>From January 2013 to December 2015, group A streptococcal serology results were available for 350 patients diagnosed with ARF in NZ and 182 patients in Northern Territory. Median peak streptococcal titers were similar in both settings. Among NZ cases, 267\/350 (76.3%) met NZ serologic diagnostic criteria, whereas 329\/350 (94.0%) met Australian criteria. By applying Australian ULN titer cut-off criteria to NZ cases, excluding chorea, ARF definite cases would increase by 17.6% representing 47 cases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>ASO and ADB values were similar in these settings. Use of high ULN cut-offs potentially undercounts definite and probable ARF diagnoses. We recommend NZ and other high-burden settings to use globally accepted, age-specific, lower serologic cut-offs to avoid misclassification of ARF.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000002190","type":"journal-article","created":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T21:35:18Z","timestamp":1537997718000},"page":"e1-e6","source":"Crossref","is-referenced-by-count":13,"title":["Streptococcal Serology in Acute Rheumatic Fever Patients"],"prefix":"10.1097","volume":"38","author":[{"given":"Susan","family":"Jack","sequence":"first","affiliation":[{"name":"Centre for International Health, Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand"},{"name":"Institute of Environmental Science and Research, Wellington, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole J.","family":"Moreland","sequence":"additional","affiliation":[{"name":"School of Medical Sciences and Maurice Wilkins Centre, University of Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jess","family":"Meagher","sequence":"additional","affiliation":[{"name":"Royal Darwin Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marea","family":"Fittock","sequence":"additional","affiliation":[{"name":"Northern Territory Rheumatic Heart Disease Control Program"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Galloway","sequence":"additional","affiliation":[{"name":"Institute of Environmental Science and Research, Wellington, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna P.","family":"Ralph","sequence":"additional","affiliation":[{"name":"Royal Darwin Hospital"},{"name":"Global and Tropical Health, Menzies School of Health Research, Darwin, Northern Territory, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230928","first-page":"1","article-title":"Group A streptococcal diseases and their global burden.","volume":"368","author":"Ralph","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"R3-20230928","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1161\/CIR.0000000000000205","article-title":"Revision of the Jones criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association.","volume":"131","author":"Gewitz","year":"2015","journal-title":"Circulation"},{"key":"R4-20230928","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/01.CIR.21.4.598","article-title":"Antibody titers in acute rheumatic fever.","volume":"21","author":"Wannamaker","year":"1960","journal-title":"Circulation"},{"key":"R5-20230928","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/INF.0000000000000881","article-title":"Streptococcal serology: secrets for the specialist.","volume":"34","author":"Steer","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"R6-20230928","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/00006454-200205000-00014","article-title":"Clinical use and interpretation of group A streptococcal antibody tests: a practical approach for the pediatrician or primary care physician.","volume":"21","author":"Shet","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"R7-20230928","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1086\/650167","article-title":"The human immune response to streptococcal extracellular antigens: clinical, diagnostic, and potential pathogenetic implications.","volume":"50","author":"Johnson","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R11-20230928","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1440-1754.2005.00726.x","article-title":"New normal ranges of antistreptolysin O and antideoxyribonuclease B titres for Australian children.","volume":"41","author":"Danchin","year":"2005","journal-title":"J Paediatr Child Health"},{"key":"R13-20230928","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1128\/CVI.00291-08","article-title":"Normal ranges of streptococcal antibody titers are similar whether streptococci are endemic to the setting or not.","volume":"16","author":"Steer","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"suppl","key":"R14-20230928","first-page":"26","article-title":"Evaluation & revaluation of upper limits of normal values of anti-streptolysin O & anti-deoxyribonuclease B in Mumbai.","volume":"119","author":"Karmarkar","year":"2004","journal-title":"Indian J Med Res"},{"key":"R15-20230928","first-page":"136","article-title":"Detection of upper limit of normal values of anti-DNase B antibody in children\u2019s age groups who were admitted to hospital with noninfectious reasons.","volume":"2","author":"Delice","year":"2015","journal-title":"North Clin Istanb"},{"key":"R16-20230928","article-title":"Anti streptolysin O; normal values for healthy children aged from 5 to 15 years old in Sana\u2019s city - Yemen.","volume":"3:1\u20135","author":"Khaled","year":"2015","journal-title":"Ann Clin Lab Res"},{"key":"R17-20230928","first-page":"1068","article-title":"Anti-streptolysin O titers in normal healthy children of 5-15 years.","volume":"40","author":"Sethi","year":"2003","journal-title":"Indian Pediatr"},{"issue":"1 pt 1","key":"R18-20230928","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1542\/peds.101.1.86","article-title":"Antistreptolysin O and anti-deoxyribonuclease B titers: normal values for children ages 2 to 12 in the United States.","volume":"101","author":"Kaplan","year":"1998","journal-title":"Pediatrics"},{"key":"R19-20230928","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1097\/INF.0b013e31826faeb3","article-title":"A national prospective surveillance study of acute rheumatic fever in Australian children.","volume":"32","author":"Noonan","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R21-20230928","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1056\/NEJM197001082820206","article-title":"Differences between streptococcal infections of the throat and of the skin (second of two parts).","volume":"282","author":"Wannamaker","year":"1970","journal-title":"N Engl J Med"},{"key":"R22-20230928","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1136\/adc.85.3.223","article-title":"Rheumatic fever in a high incidence population: the importance of monoarthritis and low grade fever.","volume":"85","author":"Carapetis","year":"2001","journal-title":"Arch Dis Child"},{"key":"R23-20230928","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S1473-3099(04)00975-2","article-title":"Acute rheumatic fever: a chink in the chain that links the heart to the throat?","volume":"4","author":"McDonald","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"R24-20230928","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1086\/506938","article-title":"Low rates of streptococcal pharyngitis and high rates of pyoderma in Australian aboriginal communities where acute rheumatic fever is hyperendemic.","volume":"43","author":"McDonald","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R25-20230928","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/INF.0000000000001558","article-title":"Acute rheumatic fever after group A streptococcus pyoderma and group G streptococcus pharyngitis.","volume":"36","author":"O\u2019Sullivan","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"R26-20230928","doi-asserted-by":"crossref","first-page":"h3443","DOI":"10.1136\/bmj.h3443","article-title":"Acute rheumatic fever.","volume":"351","author":"Webb","year":"2015","journal-title":"BMJ"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006454-201901000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T02:20:09Z","timestamp":1695867609000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201901000-00006"}},"subtitle":["Findings From 2 High-income, High-burden Settings"],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000002190","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}